The PD-1/PD-L1 pathway is a key actionable driver of immune-exhaustion in HCC, and works by suppression of T-cell receptor signalling via the PI3K/AKT pathway, ultimately inhibiting T-cell survival and growth [42, 43]. The gene discussed is CD274; the disease is hepatocellular carcinoma.